Back to 
BlackRock Advisors LLC
BlackRock Advisors LLC
NBIX
Showing 0 of 10 quarters
Position history for BlackRock Advisors LLC's holdings in Neurocrine Biosciences, Inc.
As of its last 13F, for Q4 2016, BlackRock Advisors held 616,972 shares of NBIX (Neurocrine Biosciences), worth $23.9M. It reduced the position by 326,218 shares (-34.6%) from Q3 2016. BlackRock Advisors held NBIX from Q3 2014 to Q4 2016, across 10 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.